BDX240517P270000
- 0.00
- 0.000.00%
Becton Dickinson & Co Newsroom
BD's (BDX) FDA-Approved Test to Offer Wider Testing Access
Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical specimens cannot otherwise be obtained.
Becton Dickinson & Co(BDX.US) Officer Sells US$781.22K in Common Stock
$Becton Dickinson & Co(BDX.US)$ Officer Goette Roland sold 3,300 shares of common stock on May 15, 2024 at an average price of $236.73 for a total value of $781.22K.Source: Announcement What is statem
Form 144 | Becton Dickinson & Co(BDX.US) Officer Proposes to Sell 775.5K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Becton Dickinson & Co(BDX.US)$、$Becton, Dickinson and Co(BDXB.US)$ Officer ROLAND FRIEDRICH CARL GOETTECHEMIN OCHE COMBE 4 intends to sell 3,300 shares of its common s
Becton Dickinson & Co(BDX.US) Officer Sells US$781.12K in Common Stock
$Becton Dickinson & Co(BDX.US)$ Officer Goette Roland sold 3,300 shares of common stock on May 13, 2024 at an average price of $236.7 for a total value of $781.12K.Source: Announcement What is stateme
DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300
Becton, Dickinson (BDX) has an average outperform rating and a price target range of $240 to $325, according to analysts polled by Capital IQ. Price: 234.87, Change: -0.13, Percent Change: -0.06
Express News | Bd: FDA Approval for Use of Self-Collected Vaginal Specimens for Human Papillomavirus Testing When Cervical Specimens Cannot Otherwise Be Obtained
Form 144 | Becton Dickinson & Co(BDX.US) Officer Proposes to Sell 777.71K in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Becton Dickinson & Co(BDX.US)$、$Becton, Dickinson and Co(BDXB.US)$ Officer ROLAND FRIEDRICH CARL GOETTECHEMIN OCHE COMBE 4 intends to sell 3,300 shares of its common s
Express News | NYSE Order Imbalance 58037.0 Shares on Buy Side
Express News | NYSE Order Imbalance 86851.0 Shares on Sell Side
Becton Dickinson Is Maintained at Overweight by Barclays
Becton Dickinson Is Maintained at Overweight by Barclays
Becton Dickinson Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 32.95% Barclays $305 → $312 Maintains Overweight 02/05/2024 29.96% Barclays $301 → $305 Maintai
11 Best Recession Dividend Stocks To Buy
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating
Becton, Dickinson (BDX) has an average outperform rating and a price target range of $240 to $325, according to analysts polled by Capital IQ. Price: 237.00, Change: +2.32, Percent Change: +0.99
Becton Dickinson (BDX) Receives a Buy From Barclays
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Becton, Dickinson and Company (NYSE:BDX) Q2 2024 Earnings Call Transcript
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271
Becton, Dickinson and Company (BDX) has an average rating of outperform and price targets ranging from $240 to $325, according to analysts polled by Capital IQ.
Peripheral Vascular Devices Market Is Projected to Grow at a CAGR of 8.5% by 2034: Visiongain
Stock Market News for May 3, 2024
Express News | Bd : Evercore ISI Raises Target Price to $282 From $280